Skip to main content
. 2023 May 9;128:10.48101/ujms.v128.9392. doi: 10.48101/ujms.v128.9392

Table 1.

Clinical and laboratory characteristics of patients with symptomatic and asymptomatic B-cell derived NHL. Age, hemoglobin, lactate dehydrogenase, albumin, creatinine, and C-reactive protein are expressed as median, range. N/A = not applicable.

Variable Symptomatic B-NHL (n = 35) Asymptomatic B-NHL (n = 41) P
Age (years) 69 (40–89) 71 (41–92) 0.2
Male gender (%) 49 51 N/A
Hemoglobin (g/L) 124 (51–158) 127 (110–157) 0.31
Lactate dehydrogenase (µkat/L) 2.9 (1.8–7.1) 2.6 (1.5–6.9) 0.74
Albumin (g/L) 37 (16–49) 38 (30–45) 0.2
Creatinine (µmol/L) 66 (35–207) 64 (43–104) 0.31
CRP (mg/L) 2.1 (1.3–61) 1.8 (1.1–82) 0.64
Ann Arbor stage I (n) 8 2 N/A
Ann Arbor stage II (n) 4 2 N/A
Ann Arbor stage III (n) 4 6 N/A
Ann Arbor stage IV (n) 21 29 N/A
Follicular lymphoma (n) 16 7 N/A
Waldenstrom’s macroglobulinemia (n) 5 18 N/A
Small lymphocytic lymphoma (n) 0 6 N/A
Marginal zone lymphoma (n) 2 1 N/A
Lymphoplasmacytic lymphoma (n) 1 0 N/A
Hairy cell leukemia (n) 0 1 N/A
B-cell lymphoma not otherwise specified (n) 13 6 N/A